Log In
Print
BCIQ
Print
Print this Print this
 

purified poloxamer 188 (MST-188) (formerly ANX-188)

  Manage Alerts
Collapse Summary General Information
Company Mast Therapeutics Inc.
DescriptionAnti-thrombotic poloxamer that binds to hydrophobic surfaces on damaged cells
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today